Biological evaluation of boronated unnatural amino acids as new boron carriers

Applied Radiation and Isotopes

Volumn 67, Issue 7-8 SUPPL., 2009, Pages

  Kabalka, G W ^a   Yao, M L ^a   Marepally, S R ^a   Chandra, S ^b  

^a UNIVERSITY OF TENNESSEE   (United States)

^b Institute for the Study of the Continents   (United States)

Author keywords

Amino acids; BNCT; Boron biodistribution; SIMS

Indexed keywords

BALB/C MICE; BIOLOGICAL CHARACTERIZATION; BIOLOGICAL EVALUATION; BNCT; BORON CONCENTRATIONS; BORON NEUTRON CAPTURE THERAPY; CELL LINES; CIS AND TRANS ISOMERS; COMPLEX FORMS; CYCLIC AMINO ACIDS; D-ISOMER; EXTRACELLULAR; GLIOBLASTOMA CELLS; HIGHER-DEGREE; IN-CELL; ION MICROSCOPY; ISOMERIC FORMS; ISOMERIC SEPARATION; LIVER TISSUE; MAMMARY CARCINOMA; MOUSE MODELS; NORMAL TISSUE; NUTRIENT MEDIUM; RACEMIC MIXTURES; SIMS; SIMS IMAGING; SPATIAL RESOLUTION; SUB-CELLULAR; SUBCELLULAR LOCATION; TUMOR CELLS; TUMOR TARGETING;

AMINATION; AMINES; AMINO ACIDS; ANIMAL CELL CULTURE; BEARINGS (STRUCTURAL); BLOOD; BORON COMPOUNDS; CELL CULTURE; CELL MEMBRANES; ENZYME ACTIVITY; FRUCTOSE; HISTOLOGY; ISOMERS; MIXTURES; ONCOLOGY; ORGANIC ACIDS; SECONDARY ION MASS SPECTROMETRY; TUMORS;

BORON;

1 AMINO 3 (4 BORONOBUTYL)CYCLOBUTANECARBOXYLIC ACID; 1 AMINO 3 BORONOCYCLOHEPTANECARBOXYLIC ACID; 1 AMINO 3 BORONOCYCLOHEXANECARBOXYLIC ACID; 1 AMINO 3 BORONOCYCLOPENTANECARBOXYLIC ACID; 1 AMINO 4 BORONOCYCLOHEXANECARBOXYLIC ACID; 2 AMINO 4 BORONO 2 METHYLBUTANECARBOXYLIC ACID; 4 BORONOPHENYLALANINE; AMINO ACID DERIVATIVE; BOROCAPTATE; BORON; DRUG CARRIER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; BREAST CARCINOMA; CANCER CELL CULTURE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CULTURE MEDIUM; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG TARGETING; DRUG TISSUE LEVEL; DRUG UPTAKE; ELECTRON MICROSCOPY; FREEZE DRYING; GLIOBLASTOMA; HUMAN; HUMAN CELL; ISOMER; MALE; MASS SPECTROMETRY; MOUSE; NEUTRON CAPTURE THERAPY; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RACEMIC MIXTURE; STRUCTURE ANALYSIS;

AMINO ACIDS; ANIMALS; BORON; BORON COMPOUNDS; BORON NEUTRON CAPTURE THERAPY; CELL LINE, TUMOR; DRUG CARRIERS; FEMALE; GLIOBLASTOMA; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MOLECULAR STRUCTURE; RADIATION-SENSITIZING AGENTS; SPECTROMETRY, MASS, SECONDARY ION;

EID: 67649395546     PISSN: 09698043     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apradiso.2009.03.104     Document Type: Article

References (28)

1. Aoyagi M., Agronoff G.W., Washburn L.C., and Smith O.R. Blood-brain-barrier transport of 1-aminocyclohexane carboxylic acid: a nonmetabolizable amino acid for in vivo studies of brain transport. J. Neurochem. 50 (1988) 1220-1226
2. Barth R.F., Coderre J.A., Vicente M.G.H., and Blue T.E. Boron neutron capture therapy of cancer: current status and future prospects. Clin. Cancer Res. 11 (2005) 3987-4002
3. Chandra S., Morrison G.H., and Wolcott C.C. Imaging intracellular elemental distribution and ion fluxes in cultured cells using ion microscopy: a freeze-fracture methodology. J. Microsc. 144 (1986) 15-37 Oxford
4. Chandra S., Smith D.R., and Morrison G.H. Subcellular imaging by dynamic SIMS ion microscopy. Anal. Chem. 72 (2000) 104A-114A
5. Chandra S., Lorey II D.R., and Smith D.R. Quantitative subcellular secondary ion mass spectrometry (SIMS) imaging of boron-10 and boron-11 isotopes in the same cell delivered by two combined BNCT drugs: In vitro studies on human glioblastoma T98G cells. Radiat. Res. 157 (2002) 700-710
6. 15N-labeled phenylalanine in human glioblastoma cells: relevance of subcellular scale observations to BPA-mediated boron neutron capture therapy of cancer. Int. J. Mass Spectrosc. 260 (2007) 90-101
7. Coderre J.A., and Morris G.M. The radiation biology of boron neutron capture therapy. Radiat. Res. 151 (1999) 1-18
8. Cordoso J.E., Trivillin V.A., Heber E.M., Nigg D.W., Calzetta O., Blaumann H., Longhino J., Itoiz M.E., Bumaschny E., Pozzi E., and Schwint A.E. Effect of boron neutron capture therapy (BNCT) on normal liver regeneration: towards a novel therapy for liver metastases. Int. J. Radiat. Biol. 83 (2007) 699-706
9. Dagrosa M.A., Thomacz L., Longhino J., Perona M., Calzetta O., Blaumann H., Rebagliati R.J., Cabrini R., Kahl S., Juvenal G.J., and Pisarev M.A. Optimization of boron neutron capture therapy for the treatment of undifferentiated thyroid cancer. Int. J. Radiat. Oncol. Biol. Phys. 69 (2007) 1054-1066
10. Fairchild R.G., and Bond B.P. Current status of boron-10 neutron capture therapy: enhancement of tumor dose via beam filtration and dose rate, and the effects of these parameters on minimum boron content-a theoretical evaluation. Int. J. Radiat. Oncol. Biol. Phys. 11 (1985) 831-835
11. 7Li reaction in cells and tissue and its implications for boron neutron capture therapy. Radiat. Res. 111 (1987) 14-25
12. Godwin J.T., Far L.E., Sweet W.H., and Robertson J.S. Pathological study of eight patients with glioblastoma multiforme treated by neutron-capture therapy using boron 10. Cancer 8 (1955) 601-615
13. Hatanaka, H. 1991. Boron neutron capture therapy for tumors. In: Glioma, Karim, A.B.M.F, Lewis, E.R. (Eds.), Springer, Berlin, pp. 233-249.
14. 11C]-ACBC) for detecting recurrent brain tumors. Clin. Positron Imag. 1 (1998) 165-169
15. Kabalka G.W., Das B.C., and Das S. Synthesis of novel boron containing unnatural cyclic amino acids as potential therapeutic agents. Tetrahedron Lett. 42 (2001) 7145-7146
16. Kabalka G.W., Nichols T.L., Smith G.T., Miller L.F., Khan M.K., and Busse P.M. The use of positron emission tomography to develop boron neutron capture therapy treatment plans for metastatic malignant melanoma. J. Neuro-oncol. 62 (2003) 187-195
17. Kabalka G.W., Wu Z.Z., Yao M.-L., and Natarajan N. The synthesis and in vivo biodistribution of novel boronated unnatural amino acids. Appl. Radiat. Isot. 61 (2004) 1111-1115
18. Kabalka G.W., and Yao M.-L. The synthesis and use of boronated amino acids for boron neutron capture therapy. Anti-cancer Agents Med. Chem. 6 (2006) 111-125
19. Kankaaranta L., Seppala T., Kovinoro H., Saarilhti K., Atula T., Collan J., Salli E., Kortensniemi M., Uusi-Simola J., Makitie A., Seppanen M., Minn K., Kotilnoto P., Anterinen I., Savolainen S., Kouri M., and Joensuu H. Boron neutron capture therapy in the treatment of locally recurred head and neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 69 (2007) 475-482
20. Li T., Hamdi J., and Hawthorne M.F. Unilamellar liposomes with enhanced boron content. Bioconjugate Chem. 17 (2006) 15-20
21. Miura M., Morris G.M., Micca P.L., Lombardo D.T., Youngs K.M., Kalef-Ezra J.A., Hoch D.A., Slatkin D.N., Ma R., and Coderre J.A. Boron neutron capture therapy of a murine mammary carcinoma using a lipophilic carboranyltetraphenylporphyrin. Radiat. Res. 155 (2001) 603-610
22. Nichols T.L., Kabalka G.W., Miller L.F., Khan M.K., and Smith G.T. Improved treatment planning for boron neutron capture therapy for glioblastoma multiforme using fluorine-18 labeled boronophenylalanine and positron emission tomography. Med. Phys. 29 (2002) 2351-2358
23. Pellettieri L., H-Stenstam B., Rezaei A., Giusti V., and Skold K. An investigation of boron neutron capture therapy for recurrent glioblastoma multiforme. Acta Neurol. Scand. 117 (2008) 191-197
24. Soloway A.H., Tjarks W., Barnum B.A., Rong F.-G., Barth R.F., Codogni I.M., and Wilson J.G. The chemistry of neutron capture therapy. Chem. Rev. 98 (1998) 1515-1562
25. Sweet W.H. Early history of development of boron neutron capture therapy of tumors. J. Neuro-oncol. 33 (1997) 19-26
26. Wittig A., Sauerwein W.A., and Coderre J.A. Mechanisms of transport of p-borono-phenylalanine through the cell membrane in vitro. Radiat. Res. 153 (2000) 173-180
27. 10B-compounds in liver metastases of colorectal adenocarcinoma for extracorporeal irradiation with boron neutron capture therapy (EORTC Trial 11001). Int. J. Cancer 122 (2008) 1164-1171
28. Zamenhof R.G., Kalend A.M., and Bloomer W.D. BNCT: looking for a few good molecules. J. Natl. Cancer Inst. 84 (1992) 1290-1291